High glucose-induced oxidative stress alters estrogen effects on ERα and ERβ in human endothelial cells: Reversal by AMPK activator

Journal of Steroid Biochemistry and Molecular Biology

Volumn 117, Issue 4-5, 2009, Pages 99-106

  Chakrabarti, Subhadeep ^a,b   Davidge, Sandra T ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

Author keywords

AMPK; Endothelium; Estrogen; Hyperglycemia; Receptor; Superoxide

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE; HYDROETHIDINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; EPITHELIUM CELL; ESTROGEN ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; OXIDATIVE STRESS; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

ADENYLATE KINASE; BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE; HUMANS; OXIDATIVE STRESS;

EID: 70350335550     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.07.007     Document Type: Article

References (48)

1. Roglic G. Diabetes in women: the global perspective. Int. J. Gynaecol. Obstet. 104 Suppl. 1 (2009) S11-S13
2. Booth G.L., Kapral M.K., Fung K., and Tu J.V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368 9529 (2006) 29-36
3. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 4 (1998) 229-234
4. Standl E., Muller M., and Schnell O. The impact of glucose-lowering therapy on cardiovascular outcomes. Best Pract. Res. 23 3 (2009) 401-411
5. Stork S., van der Schouw Y.T., Grobbee D.E., and Bots M.L. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol. Metab. 15 2 (2004) 66-72
6. Kanaya A.M., Grady D., and Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch. Intern. Med. 162 15 (2002) 1737-1745
7. Kannel W.B., and Wilson P.W. Risk factors that attenuate the female coronary disease advantage. Arch. Intern. Med. 155 1 (1995) 57-61
8. Lee W.L., Cheung A.M., Cape D., and Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23 7 (2000) 962-968
9. Kim J.K., and Levin E.R. Estrogen signaling in the cardiovascular system. Nucl. Recept. Signal 4 (2006) e013
10. Gray G.A., Sharif I., Webb D.J., and Seckl J.R. Oestrogen and the cardiovascular system: the good, the bad and the puzzling. Trends Pharmacol. Sci. 22 3 (2001) 152-156
11. Amant C., Holm P., Xu Sh S.H., Tritman N., Kearney M., and Losordo D.W. Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium: regulation of fas ligand expression by estradiol. Circulation 104 21 (2001) 2576-2581
12. Alvarez A., Hermenegildo C., Issekutz A.C., Esplugues J.V., and Sanz M.J. Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activation. Circ. Res. 91 12 (2002) 1142-1150
13. Dean S.A., Tan J., O'Brien E.R., and Leenen F.H. 17Beta-estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 3 (2005) R759-R766
14. Chen D.B., Bird I.M., Zheng J., and Magness R.R. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 145 1 (2004) 113-125
15. Harris H.A. Estrogen receptor-beta: recent lessons from in vivo studies. Mol. Endocrinol. 21 1 (2007) 1-13
16. Haynes M.P., Li L., Sinha D., Russell K.S., Hisamoto K., Baron R., Collinge M., Sessa W.C., and Bender J.R. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J. Biol. Chem. 278 4 (2003) 2118-2123
17. Li L., Haynes M.P., and Bender J.R. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 100 8 (2003) 4807-4812
18. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103 3 (1999) 401-406
19. Pedram A., Razandi M., and Levin E.R. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20 9 (2006) 1996-2009
20. Widder J., Pelzer T., von Poser-Klein C., Hu K., Jazbutyte V., Fritzemeier K.H., Hegele-Hartung C., Neyses L., and Bauersachs J. Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension 42 5 (2003) 991-996
21. Zhai P., Eurell T.E., Cooke P.S., Lubahn D.B., and Gross D.R. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am. J. Physiol. Heart Circ. Physiol. 278 5 (2000) H1640-H1647
22. Ihionkhan C.E., Chambliss K.L., Gibson L.L., Hahner L.D., Mendelsohn M.E., and Shaul P.W. Estrogen causes dynamic alterations in endothelial estrogen receptor expression. Circ. Res. 91 9 (2002) 814-820
23. Crabtree M.J., Smith C.L., Lam G., Goligorsky M.S., and Gross S.S. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS. Am. J. Physiol. Heart Circ. Physiol. 294 4 (2008) H1530-H1540
24. Son S.M. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes. Diabetes Res. Clin. Pract. 77 Suppl. 1 (2007) S65-S70
25. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 6779 (2000) 787-790
26. Young T.A., Wang H., Munk S., Hammoudi D.S., Young D.S., Mandelcorn M.S., and Whiteside C.I. Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent. Exp. Eye Res. 80 5 (2005) 651-662
27. Chen X.L., Zhang Q., Zhao R., and Medford R.M. Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am. J. Physiol. Heart Circ. Physiol. 286 3 (2004) H1001-H1007
28. Paravicini T.M., and Touyz R.M. Redox signaling in hypertension. Cardiovasc. Res. 71 2 (2006) 247-258
29. Tamir S., Izrael S., and Vaya J. The effect of oxidative stress on ERalpha and ERbeta expression. J. Steroid Biochem. Mol. Biol. 81 4-5 (2002) 327-332
30. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., and Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108 8 (2001) 1167-1174
31. Zou M.H., Kirkpatrick S.S., Davis B.J., Nelson J.S., Wiles W.G.t., Schlattner U., Neumann D., Brownlee M., Freeman M.B., and Goldman M.H. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. J. Biol. Chem. 279 42 (2004) 43940-43951
32. Lee W.J., Lee I.K., Kim H.S., Kim Y.M., Koh E.H., Won J.C., Han S.M., Kim M.S., Jo I., Oh G.T., Park I.S., Youn J.H., Park S.W., Lee K.U., and Park J.Y. Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler. Thromb. Vasc. Biol. 25 12 (2005) 2488-2494
33. Cacicedo J.M., Yagihashi N., Keaney Jr. J.F., Ruderman N.B., and Ido Y. AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 324 4 (2004) 1204-1209
34. Kukidome D., Nishikawa T., Sonoda K., Imoto K., Fujisawa K., Yano M., Motoshima H., Taguchi T., Matsumura T., and Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55 1 (2006) 120-127
35. Fiedler M., Zierath J.R., Selen G., Wallberg-Henriksson H., Liang Y., and Sakariassen K.S. 5-Aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice. Diabetologia 44 12 (2001) 2180-2186
36. De Jager J., Kooy A., Lehert P., Bets D., Wulffele M.G., Teerlink T., Scheffer P.G., Schalkwijk C.G., Donker A.J., and Stehouwer C.D. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J. Intern. Med. 257 1 (2005) 100-109
37. Scarpello J.H. Improving survival with metformin: the evidence base today. Diabetes Metab. 29 4 Pt 2 (2003) 6S36-6S43
38. Stewart K.G., Zhang Y., and Davidge S.T. Estrogen decreases prostaglandin H synthase products from endothelial cells. J. Soc. Gynecol. Investig. 6 6 (1999) 322-327
39. Peshavariya H.M., Dusting G.J., and Selemidis S. Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic. Res. 41 6 (2007) 699-712
40. Dyugovskaya L., Lavie P., and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med. 165 7 (2002) 934-939
41. Han J., Woytowich A.E., Mandal A.K., and Hiebert L.M. Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin. Exp. Biol. Med. (Maywood) 232 7 (2007) 927-934
42. Kernohan A.F., Spiers A., Sattar N., Hillier C., Cleland S.J., Small M., Lumsden M.A., McConnell J., and Petrie J.R. Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes. Diab. Vasc. Dis. Res. 1 2 (2004) 82-88
43. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 10 (2000) 840-844
44. Fava D., Cassone-Faldetta M., Laurenti O., De Luca O., Ghiselli A., and De Mattia G. Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in type 2 diabetes. Diabet. Med. 19 9 (2002) 752-757
45. Xie Z., Zhang J., Wu J., Viollet B., and Zou M.H. Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 57 12 (2008) 3222-3230
46. van der Loo B., Schildknecht S., Zee R., and Bachschmid M.M. Signalling processes in endothelial ageing in relation to chronic oxidative stress and their potential therapeutic implications in humans. Exp. Physiol. 94 3 (2009) 305-310
47. Wadham C., Parker A., Wang L., and Xia P. High glucose attenuates protein S-nitrosylation in endothelial cells: role of oxidative stress. Diabetes 56 11 (2007) 2715-2721
48. Garban H.J., Marquez-Garban D.C., Pietras R.J., and Ignarro L.J. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc. Natl. Acad. Sci. U.S.A. 102 7 (2005) 2632-2636